跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL DACARBAZINE 200mg Powder for Injection - TGA Drug Approval Details
Approvals
/
TGA
/
DBL DACARBAZINE 200mg Powder for Injection
Approved
STANDARD
DBL DACARBAZINE 200mg Powder for Injection
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
7d75ee041169550f
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7d75ee041169550f
Product Name
DBL DACARBAZINE 200mg Powder for Injection
Artg Id
39954
Artg Name
DBL DACARBAZINE 200mg powder for injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1992-07-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4c72cde5ac024c24397f48224f05a6be.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5061ecf360e7efab22ce4b933a18169d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
7d75ee041169550f
Type
Standard
Back to TGA Approvals